Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 15, Issue 5, Pages 586-592
Publisher
Informa UK Limited
Online
2014-02-21
DOI
10.4161/cbt.28164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin for aging and cancer prevention
- (2016) Vladimir N. Anisimov Aging-US
- If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
- (2016) Vladimir N. Anisimov et al. Aging-US
- Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
- (2016) Mikhail V. Blagosklonny Aging-US
- Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
- (2016) Olga V. Leontieva et al. Aging-US
- Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
- (2016) Elena A. Komarova et al. Aging-US
- New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
- (2016) Maria Comas et al. Aging-US
- Prolonged Rapamycin treatment led to beneficial metabolic switch
- (2016) Yimin Fang et al. Aging-US
- Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer
- (2016) Vladimir N. Anisimov Aging-US
- Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
- (2016) Lan Ye et al. Aging-US
- Immunostimulatory activity of lifespan-extending agents
- (2016) José Manuel Bravo-San Pedro et al. Aging-US
- Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
- (2016) Carolina B. Livi et al. Aging-US
- Metformin, aging and cancer
- (2016) Olga Moiseeva et al. Aging-US
- Exploiting the mTOR paradox for disease prevention
- (2015) Ramiro Iglesias-Bartolome et al. Oncotarget
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- eRapa Restores a Normal Life Span in a FAP Mouse Model
- (2013) P. Hasty et al. Cancer Prevention Research
- Rapamycin prolongs female reproductive lifespan
- (2013) Li-li Luo et al. CELL CYCLE
- Metformin: Do we finally have an anti-aging drug?
- (2013) Vladimir N. Anisimov CELL CYCLE
- Rapamycin extends murine lifespan but has limited effects on aging
- (2013) Frauke Neff et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin Extends Life and Health in C57BL/6 Mice
- (2013) Yiqiang Zhang et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
- (2013) S. C. Johnson et al. SCIENCE
- Drugs that modulate aging: the promising yet difficult path ahead
- (2013) Brian K. Kennedy et al. Translational Research
- Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence
- (2013) Yi Luo et al. TRANSPLANTATION
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression
- (2013) J. Julie Wu et al. Cell Reports
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Rapalogs in cancer prevention
- (2012) Mikhail V. Blagosklonny CANCER BIOLOGY & THERAPY
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
- (2012) Ramiro Iglesias-Bartolome et al. Cell Stem Cell
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Metformin slows down aging and extends life span of female SHR mice
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Increasing healthy lifespan by suppressing aging in our lifetime: Preliminary proposal
- (2011) Mikhail V Blagosklonny CELL CYCLE
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevention of cancer by inhibiting aging
- (2010) Mikhail V Blagosklonny CANCER BIOLOGY & THERAPY
- Rapamycin and quasi-programmed aging: Four years later
- (2010) Mikhail V Blagosklonny CELL CYCLE
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
- (2009) C. Chen et al. Science Signaling
- Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells
- (2008) Mikhail V. Blagosklonny REJUVENATION RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started